The regulation of biotechnology products at the national and international level inevitably involves private sector companies. Biotechnology firms are, in many ways, the “street-level bureaucrats” of biotechnology, those expected to enforce and implement government regulations regarding biotechnology products. Not only are they the front-line producers and distributors of the technology, a fact which places them well to provide insights and channel their experience into the design of regulatory systems, but the in-house scientific expertise they have and the level of capital they own, make them key advisers and powerful political players in the politics of biotechnology regulation. This paper analyses the political role of the firms that ar...
Why do corporations develop technologies which can be associated with the generation of various envi...
Biological risk régulation vs innovation ? This paper discusses strategie décision making in firms...
The administrative handling of regulatory oversight procedures differs from country to country, wher...
This paper seeks to identify and explain the ways in which different firms affected by and involved ...
Multinational companies in the life science sector are heavily influenced by government policies and...
Biotechnology has triggered a spirited debate about how to assess risks, what rules to use, and wher...
Little is known about the factors that influence regulatory-agency decision making. We posit that re...
This book is available as open access through the Bloomsbury Open Access programme and is available ...
This paper discusses strategic decision making in firms pursuing biotechnology innovation and the in...
This paper looks at the politics of biosafety regulation in China. Policy processes around GM crops ...
This paper considers the challenges entailed in applying the principles and methods of public partic...
This paper asks what regulation actually means in practice in the post-economic reform context of In...
The emergence of new fundamental knowledge in life sciences is leading to new, "breakthrough" techno...
[From the introduction]. In this book we investigate these challenges – regulating risk in a global ...
There has been much recent debate about the declining public trust in science, scientific institutio...
Why do corporations develop technologies which can be associated with the generation of various envi...
Biological risk régulation vs innovation ? This paper discusses strategie décision making in firms...
The administrative handling of regulatory oversight procedures differs from country to country, wher...
This paper seeks to identify and explain the ways in which different firms affected by and involved ...
Multinational companies in the life science sector are heavily influenced by government policies and...
Biotechnology has triggered a spirited debate about how to assess risks, what rules to use, and wher...
Little is known about the factors that influence regulatory-agency decision making. We posit that re...
This book is available as open access through the Bloomsbury Open Access programme and is available ...
This paper discusses strategic decision making in firms pursuing biotechnology innovation and the in...
This paper looks at the politics of biosafety regulation in China. Policy processes around GM crops ...
This paper considers the challenges entailed in applying the principles and methods of public partic...
This paper asks what regulation actually means in practice in the post-economic reform context of In...
The emergence of new fundamental knowledge in life sciences is leading to new, "breakthrough" techno...
[From the introduction]. In this book we investigate these challenges – regulating risk in a global ...
There has been much recent debate about the declining public trust in science, scientific institutio...
Why do corporations develop technologies which can be associated with the generation of various envi...
Biological risk régulation vs innovation ? This paper discusses strategie décision making in firms...
The administrative handling of regulatory oversight procedures differs from country to country, wher...